Blue Bioeconomy Roadmap for Portugal 12 April 2019 The Blue Bioeconomicy Roadmap for Portugal, which resulted from a joint work of CIIMAR, BLUEBIO ALLIANCE and Fundação
The Book of Proceedings of the BLUEandGREEN Legacy International Conference and Workshop – Adding Value to Marine Bioresources is now available Find it Here.
High Throughput Screening and Safety 5 – 7 November 2018 Bioactivity screening is an important process in the discovery of novel compounds from marine resources. T
Participant 1 / Portugal
CIIMAR is a non-profit research and advanced training institution hosted by the University of Porto. Its mission is to develop exceptional-quality research, promote technological development and support public policies in the area of Marine and Environmental Sciences. CIIMAR is a multidisciplinary institution, organized into 3 Thematic Lines: Global Changes and Ecosystem Services, Aquaculture and Seafood safety and Marine Biotechnology.
Participant 2 / Finland
University of Helsinki is the largest university in Finland and concentrates on high-level scientific research and education. The group of Prof. Kaarina Sivonen has carried our pioneering research on cyanobacterial bioactive compounds including studies on their structures, bioactivities as well as biosynthesis. One of the main focuses in recent years has been the genome based analysis of cyanobacteria and their bioactive compounds. The group of Prof. Karina Sivonen has extensive experience on the organization and implementation of intensive post-graduation courses.
Participant 3 / Norway
University of Bergen is a young and modern university, involved in 109 FP7 projects, 38 of which it coordinates; among them 7 ERC Advanced Grants, 1 ERC Starting Grant and 1 ERC Synergy Grant. To date, UiB has been awarded 18 projects under H2020. The group of Prof. Lars Herfindal has carried out screening for anti-cancer compounds, bioactivity-guided isolation of active compounds, and elucidation of mechanism of action of cyanobacterial compounds. In recent years he has built a laboratory facility for production of therapeutic nanocarriers, a major purpose being to improve the pharmacokinetic properties of drugs and drug candidates.
Participant 4 / Germany
GEOMAR Centre for Marine Biotechnology is one of the leading institutes in marine sciences in Europe. The Kiel Centre for Marine Natural Products directed by Prof. Deniz Tasdemir was established as competence centre for marine natural product research. With its outstanding infrastructure, it serves as an excellent platform for developing small molecules from the marine habitat into drug leads and other functional ingredients. This includes dereplication/secondary metabolite profiling and bioactivity screening of the crude extracts, purification and characterization of their chemical structures and various bioassays to determine the application potential of metabolites. GEOMAR, a
Centre of Helmholtz Association, is one of the leading institutes in the area of technology transfer and market-oriented research.
Participant 5 / Spain
Fundación MEDINA (MEDINA, Spain) is a non-profit public-private research organization focused on the discovery of novel bioactive compounds from microbial origin. MEDINA has more than 50 years’ inherited experience in natural products (NPs) drug discovery, with expertise in fungal and bacterial microbiology, NPs chemistry (isolation and structural elucidation), and HTS using cutting-edge screening technologies. The research group of Dr Francisca Vicente is skilled in HTS technologies, including the use of high throughput equipment, transfer of assays to robotic stations, assay validation and availability of a broad array of assay technologies normally used at MEDINA for NPs libraries screening. MEDINA is a leading institution in the application of research towards innovation, in special in the natural products area.